We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Emergency-Use Authorization for Anthrax Vaccine
FDA Issues Emergency-Use Authorization for Anthrax Vaccine
January 31, 2005
The FDA issued an emergency-use authorization (EUA) Jan. 31 for military use of anthrax vaccine, marking the first time the agency has used its EUA power since it was granted the emergency authority last summer with the passage of Project BioShield.